Zivo Bioscience Operating Margin Growth & History (ZIVO)
Zivo Bioscience's operating margin was −8,498.85% for fiscal 2024.
View full Zivo Bioscience company overviewZivo Bioscience annual operating margin history
2010
2011
2020
2023
2024
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −8,498.85% | +17768.82 pp |
| 2023 | 2023-12-31 | −26,267.67% | — |
| 2020 | 2020-12-31 | −42,778.38% | — |
| 2011 | 2011-12-31 | −1,865.71% | +3043.38 pp |
| 2010 | 2010-12-31 | −4,909.09% | — |
Zivo Bioscience quarterly operating margin
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.20
Q2.23
Q3.23
Q4.23
Q1.24
Q3.24
Q4.24
Q2.25
Q3.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2025 | 2025-09-30 | −1,551.76% | +5622.96 pp |
| Q2 2025 | 2025-06-30 | −3,057.81% | — |
| Q4 2024 | 2024-12-31 | −1,773.80% | +14298.95 pp |
| Q3 2024 | 2024-09-30 | −7,174.72% | +6150.60 pp |
| Q1 2024 | 2024-03-31 | −3,571.78% | — |
| Q4 2023 | 2023-12-31 | −16,072.75% | — |
| Q3 2023 | 2023-09-30 | −13,325.32% | — |
| Q2 2023 | 2023-06-30 | −45,033.73% | — |
| Q1 2020 | 2020-03-31 | −12,030.61% | — |
| Q4 2011 | 2011-12-31 | −23,726.96% | — |
| Q3 2011 | 2011-09-30 | −798.86% | +2066.80 pp |
| Q2 2011 | 2011-06-30 | −946.71% | +8560.52 pp |
| Q1 2011 | 2011-03-31 | −1,177.81% | — |
| Q3 2010 | 2010-09-30 | −2,865.66% | — |
| Q2 2010 | 2010-06-30 | −9,507.23% | — |
Zivo Bioscience operating margin trends
Between the periods ended 2010-12-31 and 2024-12-31, Zivo Bioscience's operating margin decreased from −4,909.09% to −8,498.85%, a change of −3589.76 percentage points. The latest reported quarter, Q3 2025, shows −1,551.76%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zivo Bioscience source filings ↗